» Articles » PMID: 15677558

SAP Controls the Cytolytic Activity of CD8+ T Cells Against EBV-infected Cells

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2005 Jan 29
PMID 15677558
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

The adaptor protein SAP regulates signaling through signaling lymphocytic activation molecule (SLAM)-family receptors expressed on T and natural killer (NK) cells. In patients affected by X-linked lymphoproliferative (XLP) disease, mutations in the SH2D1A gene result in defective lytic activity. However, the mechanism by which SAP controls cytotoxic activity remains unclear. T-cell-receptor (TCR) activation of CD8(+) cytotoxic T cells (CTLs) results in down-regulation of SAP, suggesting that this protein is involved in early activation events. Here, we show that SAP-deficient CTLs from patients with XLP and hemophagocytic lymphohistiocytosis (HLH) display a specific lytic defect against autologous and allogeneic Epstein-Barr virus (EBV)-positive B cells. This defect is associated with the defective polarization of 2B4, perforin, and lipid rafts at the contact area of CTLs with EBV-positive targets. Blockade of 2B4 in normal CTLs reproduces the defects in lysis and polarization observed in SAP-deficient CTLs. Expression and regulation of the SLAM-family receptors SLAM, CD84, and 2B4, as well as the lytic effectors perforin and granzyme-B are normal in SAP-deficient CTLs. In addition, TCR stimulation leads to normal proliferation and production of interleukin 2 (IL-2), IL-4, and interferon-gamma (IFN-gamma). These results demonstrate that the SAP/2B4 pathway plays a key role in CTL lytic activity against EBV-positive targets by promoting the polarization of the lytic machinery.

Citing Articles

SLAMF6 enables efficient attachment, synapse formation, and killing of HIV-1-infected CD4 T cells by virus-specific CD8 T cells.

Monel B, Lamothe P, Meyo J, McLean A, Quinones-Alvarado R, Laporte M bioRxiv. 2025; .

PMID: 39896504 PMC: 11785116. DOI: 10.1101/2025.01.20.633914.


Imaging of biphasic signalosomes constructed by checkpoint receptor 2B4 in conventional and chimeric antigen receptor-T cells.

Matsushima R, Wakamatsu E, Machiyama H, Nishi W, Yoshida Y, Nishikawa T iScience. 2025; 28(1):111669.

PMID: 39886466 PMC: 11780131. DOI: 10.1016/j.isci.2024.111669.


Lentiviral vectors for precise expression to treat X-linked lymphoproliferative disease.

Ayoub P, Gensheimer J, Lathrop L, Juett C, Quintos J, Tam K Mol Ther Methods Clin Dev. 2024; 32(4):101323.

PMID: 39309261 PMC: 11415656. DOI: 10.1016/j.omtm.2024.101323.


Genetics of Primary Hemophagocytic Lymphohistiocytosis.

Karageorgos S, Platt A, Bassiri H Adv Exp Med Biol. 2024; 1448:75-101.

PMID: 39117809 DOI: 10.1007/978-3-031-59815-9_7.


"Find Me" and "Eat Me" signals: tools to drive phagocytic processes for modulating antitumor immunity.

Xiao L, Zhang L, Guo C, Xin Q, Gu X, Jiang C Cancer Commun (Lond). 2024; 44(7):791-832.

PMID: 38923737 PMC: 11260773. DOI: 10.1002/cac2.12579.